Study suggests a way to stop HIV in its tracks

December 1, 2017, Loyola University Health System
HIV-1 Virus. Credit: J Roberto Trujillo/Wikipedia

When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Now, a Loyola University Chicago study has discovered the protein that helps the virus travel so fast. Researchers found that without this protein, the virus became stranded in the cytoplasm, where it was detected by the viral defense system. (The cytoplasm is the portion of the cell outside the nucleus.)

"By preventing its normal movement, we essentially turned HIV-1 into a sitting duck for cellular sensors," said Edward M. Campbell, PhD, corresponding author of the study, published in the Proceedings of the National Academy of Sciences. Campbell is an associate professor in the Department of Microbiology and Immunology of Loyola University Chicago Stritch School of Medicine.

HIV-1 infects and kills immune system cells, including T cells and macrophages that were used in the study. This cripples the immune system, making the patient vulnerable to common bacteria, viruses and other pathogens that are usually harmless in people with healthy immune systems.

After HIV-1 enters a cell, it has to work its way through the cytoplasm to the nucleus. Once inside the nucleus, HIV-1 takes control of the cell and makes additional HIV-1 copies. But getting through the cytoplasm is not easy. Cytoplasm consists of fluid that is thick with proteins and structures such as mitochondria. "Something the size of a virus cannot just diffuse through the cytoplasm," Campbell said. "It would be like trying to float to the bathroom in a very crowded bar. You need to have a plan."

HIV-1 is able to get to the nucleus quickly via tubular tracks called microtubules. The virus attaches itself to a molecular motor called dynein, which moves down the microtubule like a train car on tracks.

Campbell and colleagues discovered the "ticket" HIV-1 needs to get on the train—a protein called bicaudal D2. HIV-1 binds to bicaudal D2, which recruits the dynein . The dynein then transports HIV-1 towards the .

The finding raises the possibility of developing a drug that would prevent HIV-1 from binding to bicaudal D2, thus stranding the in the . This would not only prevent infection, but also give the cell time to turn on antiviral genes that would protect it and neighboring from infection.

The study is titled "Bicaudal D2 facilitates the cytoplasmic trafficking and nuclear import of HIV-1 genomes during infection."

Explore further: Study reveals how HIV enters cell nucleus

More information: Adarsh Dharan et al, Bicaudal D2 facilitates the cytoplasmic trafficking and nuclear import of HIV-1 genomes during infection, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1712033114

Related Stories

Study reveals how HIV enters cell nucleus

June 21, 2016
Loyola University Chicago scientists have solved a mystery that has long baffled HIV researchers: How does HIV manage to enter the nucleus of immune system cells?

Protein identified as important trigger of antiviral response

May 7, 2014
Cells have to protect themselves: against damage in their genetic material for one thing, but also against attack from the outside, by viruses for example. They do this by using different mechanisms: special proteins search ...

HIV infection hijacks intracellular highways

September 27, 2017
A Northwestern Medicine study found the human immunodeficiency virus (HIV) uses proteins called diaphanous-related formins (DRFs) to hijack the cytoskeleton of healthy cells, findings that deepen the understanding of HIV ...

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Recommended for you

Discovery of how HIV hedges its bets opens the door to new therapies

May 10, 2018
A stem cell is one with infinite possibilities. So, for decades, scientists have puzzled over how the cell chooses to keep being a stem cell and continue dividing, or specialize into a specific cell type, like a heart or ...

Researchers find link between crystal methamphetamine and immune changes in HIV

May 4, 2018
A researcher at the University of Miami Miller School of Medicine has found that the use of stimulants, such as methamphetamine, can negatively affect the health of HIV-positive persons even when they are adhering to medical ...

Study challenges 'shock and kill' approach to eliminating HIV

May 1, 2018
Researchers have provided new insight into the cellular processes behind the 'shock and kill' approach to curing HIV, which they say challenges the effectiveness of the treatment.

State-of-the-art HIV drug could curb HIV transmission, improve survival in India

April 30, 2018
An HIV treatment regimen already widely used in North America and Europe would likely increase the life expectancy of people living with HIV in India by nearly three years and reduce the number of new HIV infections by 23 ...

Risks to babies of mothers with HIV from three antiretroviral regimens appear to be low

April 25, 2018
The risk for preterm birth and early infant death is similar for three antiretroviral drug regimens taken by pregnant women with HIV according to a new study from Harvard T.H. Chan School of Public Health.

New method allows scientists to study how HIV persists

April 24, 2018
After 35 years of rigorous research, there is still no cure for HIV. Current drugs can be used to halt the infection, but fall short of reaching hidden reserves of dormant virus that can lurk for life within infected white ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.